Search for: "Sanofi S A"
Results 41 - 60
of 926
Sorted by Relevance
|
Sort by Date
1 Dec 2010, 11:40 am
"It's an interesting idea in principle,"... [read post]
16 Sep 2013, 4:00 am
The FCA overturned the trial court’s findings that Sanofi’s clopidogrel patent was invalid for inutility and obviousness. [read post]
21 Feb 2021, 9:59 pm
The case arose when Amgen sued Sanofi and Regeneron over sales of Praluent® (alirocumab), which allegedly competes with Amgen's Repatha™... [read post]
15 Dec 2023, 1:16 pm
The post Sanofi Abandons Deal For Rare Disease Drug Amid FTC’s Monopoly Concerns appeared first on Above the Law. [read post]
8 Sep 2010, 2:37 am
Sanofi-Aventis's chief executive Chris Viehbacher took his case for a takeover directly to Genzyme's investors in meetings in New York Tuesday, Bloomberg News reported, citing two people who attended. [read post]
8 Aug 2008, 3:01 pm
Court of Appeals for the Federal Circuit gave the thumbs up to a district court decision that Plaintiff-Appellant Novo Nordisk A/S wasn't getting a preliminary injunction out of Sanofi-Aventis after alleging that Sanofi's SoloStar product infringed claims of Novo's U.S. [read post]
10 Feb 2012, 12:39 pm
In early 2006, Bristol-Myers and France's Sanofi, which at the time was Sanofi-Aventis, reached a confidential settlement with Apotex to pay the Canadian company at least $40 million to delay selling generic Plavix until at least 2011, when the drug's primary patent was to expire. [read post]
27 Jul 2010, 9:56 pm
Sanofi-Aventis, et al. v. [read post]
19 Feb 2008, 1:23 am
Pharmaceutical company Sanofi-Aventis filed a complaint in Los Angeles, California District Court seeking a declaratory judgment that three medical device patents are invalid and not infringed by Sanofi's syringes. [read post]
2 Feb 2007, 12:16 pm
Such a deal would be a short-term fix that does nothing to address the drug industry’s big problems: a declining pipeline and fewer medicines reaching patients. [...] [read post]
4 Nov 2022, 3:49 pm
Sanofi, and patent enablement appeared first on PatentAssociate.com. [read post]
13 Sep 2010, 4:45 am
Sanofi-Aventis, France's largest drugmaker, arranged about $10 billion of underwritten loans to back its bid for U.S. biotechnology company Genzyme, two people familiar with the situation said. [read post]
2 Aug 2023, 11:05 am
Sanofi argued on appeal that the Board erroneously agreed with Mylan’s argument that de Gennes constituted analogous art because Mylan incorrectly compared the de Gennes reference to another prior art reference, and not the ’614 patent. [read post]
31 Aug 2010, 4:30 am
" That, in a nutshell, is the message Chris Viehbacher, the chief executive of Sanofi-Aventis, is sending the management of the biotech company Genzyme in making public his $18.5 billion offer to buy it. [read post]
26 Aug 2010, 7:03 am
A federal judge has denied a bid by Sanofi-Aventis to halt sales of a generic version of its blockbuster blood thinner Lovenox, a move which may help pave the way for the Food and Drug Administration to approve generic biologic... [read post]
8 Nov 2010, 11:58 am
Sanofi-Aventis on Monday sent a letter to Genzyme's chief executive, asking that the biotech giant not seek to block its unsolicited takeover bid by altering its board or using anti-takeover laws in its home state, Massachusetts. [read post]
23 Jan 2013, 6:23 am
Because Hyalgan and similar drugs from Sanofi’s competitors were reimbursed at the same rate by Medicare, there was a greater incentive for physicians to use Hyalgan. [read post]
4 Nov 2022, 3:49 pm
Sanofi, and patent enablement appeared first on PatentAssociate.com. [read post]
16 Dec 2008, 5:16 am
Noonan --Denial of an ANDA validity challenge by generic pharmaceutical company Apotex of Sanofi-Synthelabo's Orange Book-listed patent for Plavix ® was affirmed by the Federal Circuit last week. [read post]
10 Feb 2011, 9:22 am
It’s also wise to look for specific information about elevated risks for people with select medical conditions. [read post]
